EUVIMEDEUVIMED entdecken
Open Access

LINC00184 promotes esophageal squamous cell carcinoma progression via DNMT1‑mediated methylation of the NDRG2 promoter and PI3K/AKT pathway activation

Junjun Guo, Shenbo Fu, Jia Liu, Lina Li, Jin Zhao, Fenggang Wang, Wenan Wu, Xu Chen, Enxiao Li

Oncology Letters · 28.04.2026 · 32 (1) · 1-13

DOI: 10.3892/ol.2026.15628 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 28.04.2026. Verfasst von Junjun Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shaanxi Provincial Tumor Hospital, Xi'an, Shaanxi 710061, P.R. China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AKTDNA methyltransferase 1LINC00184N-Myc downstream regulated gene 2esophageal squamous cell carcinoma

Autor:innen und Institutionen

  • Department of Oncology, Shaanxi Provincial Tumor Hospital, Xi'an, Shaanxi 710061, P.R. China.
  • Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.
  • Department of Radiation Oncology, Shaanxi Provincial Tumor Hospital, Xi'an, Shaanxi 710061, P.R. China.
  • Department of Thoracic Surgery, Shaanxi Provincial Tumor Hospital, Xi'an, Shaanxi 710061, P.R. China.
  • Department of Internal Medicine, Shaanxi Provincial Tumor Hospital, Xi'an, Shaanxi 710061, P.R. China.

Zitieren

APA

Guo, J., Fu, S., Liu, J., Li, L., Zhao, J., Wang, F., Wu, W., Chen, X., & Li, E. (2026). LINC00184 promotes esophageal squamous cell carcinoma progression via DNMT1‑mediated methylation of the NDRG2 promoter and PI3K/AKT pathway activation. Oncology Letters, 32(1), 1-13. https://doi.org/10.3892/ol.2026.15628

Vancouver

Guo J, Fu S, Liu J, Li L, Zhao J, Wang F, et al. LINC00184 promotes esophageal squamous cell carcinoma progression via DNMT1‑mediated methylation of the NDRG2 promoter and PI3K/AKT pathway activation. Oncology Letters. 2026;32(1):1-13. doi:10.3892/ol.2026.15628

BibTeX
@article{Guo2026,
  author = {Guo, Junjun and Fu, Shenbo and Liu, Jia and Li, Lina and Zhao, Jin and Wang, Fenggang and Wu, Wenan and Chen, Xu and Li, Enxiao},
  title = {LINC00184 promotes esophageal squamous cell carcinoma progression via DNMT1‑mediated methylation of the NDRG2 promoter and PI3K/AKT pathway activation},
  journal = {Oncology Letters},
  year = {2026},
  volume = {32},
  number = {1},
  pages = {1--13},
  doi = {10.3892/ol.2026.15628}
}
Kostenlos starten →